U.S. Energy Services Stock News

USA Compression Partners reported third quarter 2025 results, showing sales of US$244.89 million and net income of US$34.49 million, both higher than the prior year, along with a US$622,000 impairment charge relating to long-lived assets. The company’s significant improvement in earnings per share compared to last year highlights robust operational performance during the period. We’ll explore how this strong year-over-year net income growth could impact USA Compression Partners’ overall...

Perella Weinberg Partners (PWP) recently reported third-quarter results that missed forecasts, with revenue declining as traditional mergers and acquisitions work slowed. Management described this as a transition phase and pointed to ongoing, strong client activity. See our latest analysis for Perella Weinberg Partners. PWP shares have felt the weight of cooling deal activity this year, with a 20.6% year-to-date share price decline and a one-year total shareholder return of -25%. However,...

Energizer Holdings (ENR) has seen its stock drift lower over the past month, sliding around 4%. With the company showing modest annual revenue and profit growth, investors may be eyeing longer-term trends instead of short-term moves. See our latest analysis for Energizer Holdings. Energizer Holdings’ shares have lost momentum recently, with a 1-day share price return of -1.53% and a 30-day slide of -4.06%. That drop caps a challenging start to the year, as its year-to-date share price return...

In the past week, Disc Medicine announced the initiation of a Phase 1b clinical trial for DISC-3405 in adults with sickle cell disease and reported the FDA's priority review of its New Drug Application for bitopertin in erythropoietic protoporphyria, alongside a public offering of approximately US$250 million in support of commercialization and R&D. A key insight is that these clinical and regulatory advances highlight Disc Medicine’s emphasis on expanding its pipeline for hematological...

National HealthCare (NHC) shares have seen steady movement this month, closing at $128.12 after a 5% rise. Investors are watching as the company’s returns have outperformed in the past 3 months. See our latest analysis for National HealthCare. Momentum has been building for National HealthCare, as the 18.9% 90-day share price return signals growing investor confidence and reflects a trend of strong long-term total shareholder returns. The stock is up more than 125% over the past three and...

Olin (OLN) just unveiled a long-term supply agreement with Braskem, aimed at supporting Braskem’s transformation of its Brazilian chlor-alkali and vinyl assets. This move directs Olin’s ethylene dichloride expertise toward international growth opportunities. See our latest analysis for Olin. Olin’s new partnership with Braskem follows a recent dividend affirmation and the dissolution of its Blue Water Alliance joint venture, signaling a sharp pivot toward growth markets. Despite these...

The board of Ball Corporation ( NYSE:BALL ) has announced that it will pay a dividend of $0.20 per share on the 15th of...

Permian Resources (PR) caught investors’ attention after management raised its 2025 oil and total production targets, reflecting continued well performance. The guidance boost, which came alongside strong quarterly production growth, suggests management’s confidence in the company’s operational momentum. See our latest analysis for Permian Resources. After a rocky start to the year, Permian Resources’ 1-month share price return of nearly 11% is turning heads. This increase suggests that the...

Ryder System (R) continues to attract attention from investors curious about its recent performance, especially given the shifts in transportation and logistics demand this year. Shares have seen movement that reflects both broader market trends and company updates. See our latest analysis for Ryder System. Ryder System’s share price has ebbed and flowed this year, recently pulling back about 6.5% over the past month even as its year-to-date gain sits near 9%. While momentum has cooled a bit...

AIRO Group Holdings (AIRO) is drawing attention after it announced new joint ventures, including a partnership with Nord-Drone, to ramp up defense drone production for U.S., NATO, and Ukraine forces. These collaborations represent an important step in their expansion strategy. See our latest analysis for AIRO Group Holdings. Despite a flurry of joint ventures and an upsized capital raise signaling AIRO’s determination to scale, the market has responded with caution. A 1-month share price...

Whirlpool Corporation recently announced significant executive leadership changes, including the appointment of Roxanne Warner as Chief Financial Officer and new roles for key executives, with transitions effective January 1, 2026. This reshaping of the senior leadership team signals a realignment of Whirlpool's management and operational structure at a time of ongoing business transformation and portfolio adjustments. We'll now examine how recent leadership transitions may influence...

Nu Holdings (NYSE:NU) has seen its stock edge slightly higher recently, reflecting ongoing interest in the digital banking sector. Investors are watching closely as the company continues to grow revenue and net income at a healthy pace. See our latest analysis for Nu Holdings. After a notable 48.8% year-to-date share price return, Nu Holdings’ momentum has clearly caught investors’ attention, especially with its strong 18.7% gain over the past three months. Looking at a longer timeframe, the...

CNH Industrial (NYSE:CNH) took center stage at Agritechnica 2025, launching new tech-forward products and earning international recognition for its brands. However, investors are weighing these advances against recent credit downgrades and a weaker earnings picture. See our latest analysis for CNH Industrial. Despite rolling out award-winning innovations at Agritechnica and launching ambitious tech initiatives, CNH Industrial’s share price has lost momentum, down over 17% in the past three...

Catalyst Pharmaceuticals (CPRX) surprised investors by delivering stronger revenue and net income growth for the recent quarter. The company also raised its revenue guidance for 2025, signaling confidence in its ongoing business momentum. See our latest analysis for Catalyst Pharmaceuticals. On top of the upbeat earnings, Catalyst Pharmaceuticals’ share price steadily climbed, up nearly 13% over the past month and 15% in the last 90 days. The one-year total shareholder return stands at a...

Mondelez International (MDLZ) shares have been under pressure recently, with the stock declining about 9% over the past month. Investor sentiment appears cautious, even though the company’s annual revenue and net income have grown at solid rates. See our latest analysis for Mondelez International. The past year has seen momentum fade for Mondelez International, with the latest share price at $56.86 and a 1-year total shareholder return of -9.2%. Despite periods of revenue and earnings growth,...

MACOM Technology Solutions Holdings (MTSI) just posted fourth-quarter earnings that surpassed forecasts, showing a sharp increase in both sales and income compared to last year. The company also offered a solid revenue outlook for the upcoming quarter. See our latest analysis for MACOM Technology Solutions Holdings. MACOM’s latest results have powered the stock’s impressive run, even after a brief dip tied to chip sector volatility and insider sales earlier this month. The share price is up...

Americold Realty Trust (COLD) just released its third-quarter results, reporting a year-over-year decline in sales and revenue, along with a larger net loss. Management also maintained a cautious outlook for the rest of the year and expects flat to slightly negative same-store growth. See our latest analysis for Americold Realty Trust. This tougher quarter has weighed heavily on sentiment, with Americold’s 1-month share price return down 20.9% and its year-to-date loss stretching to nearly...

CG Oncology announced it has initiated a rolling Biologics License Application submission to the U.S. FDA for cretostimogene, its therapy for high-risk non-muscle invasive bladder cancer, and completed enrollment ahead of schedule for its pivotal Phase 3 trial in intermediate-risk disease. These key steps reflect strong clinical momentum and signal growing stakeholder and physician interest in the company’s urologic oncology pipeline. With these milestones, we’ll explore how accelerated...

PennyMac Financial Services (PFSI) has seen its stock steadily climb over the past month, gaining about 6%. Investors are taking a closer look at what is behind this momentum and where the valuation stands now. See our latest analysis for PennyMac Financial Services. While the last month’s 5.8% share price return has grabbed attention, PennyMac’s momentum is part of a longer trend. Its year-to-date share price return stands at a robust 27.2%, and the one-year total shareholder return is...

Encompass Health (EHC) has delivered steady growth recently, with annual revenue and net income both climbing over the past year. Shares have returned 23% year to date, which is a result that stands out among healthcare peers. See our latest analysis for Encompass Health. Encompass Health’s share price has cooled in the past month, down nearly 9%, even after posting strong year-to-date momentum and a 15.5% total shareholder return over the last year. Despite some recent volatility, the steady...

IMAX (NYSE:IMAX) is creating buzz by bringing Stanley Kubrick’s The Shining to IMAX theaters for the first time, starting December 12, 2025. This move taps into classic cinema nostalgia for a new audience. See our latest analysis for IMAX. IMAX’s strategy of bringing cinematic classics to its theaters is resonating with the market and fueling momentum in the share price over the past few months. The company’s 1-month share price return of nearly 9% and a remarkable 36% gain over the past 90...

Similarweb (NYSE:SMWB) drew attention this week after unveiling third-quarter earnings. The company posted adjusted earnings that exceeded expectations, although revenue came in a bit under what analysts had anticipated. See our latest analysis for Similarweb. Even with revenue growth and new guidance forecasting double-digit gains next year, Similarweb’s 1-year total shareholder return is down 36.1%. Weak share price momentum in recent months reflects cautious sentiment after the latest...

Johnson & Johnson (JNJ) shares have caught investors’ attention following recent movement in the stock price. With modest gains over the past week, many are looking for signals that could set the tone for the coming months. See our latest analysis for Johnson & Johnson. Johnson & Johnson’s recent share price momentum has caught the market’s eye, with the stock gaining over 5% in the last week and climbing 36% year-to-date. When you zoom out, the company has quietly notched up a 31% total...

On November 6, 2025, Immunome, Inc. announced financial results for the third quarter and nine months ended September 30, reporting a lower net loss and improved loss per share compared to the previous year. This performance highlights progress in Immunome's operational efficiency and a strengthening financial position within a competitive biotechnology landscape. We'll explore how Immunome's narrowing losses and operational improvements influence its evolving investment narrative in the...